Healthcare Services Acquisitions in Canada

FluidAI Medical, a Canadian medical technology company, has acquired Emmetros Limited, the developer of the SparxConnect patient engagement and collaboration platform. The deal expands and strengthens FluidAI’s Stream Inara AI-powered patient education and engagement product within its RISE (Recovery Intelligence and Surgical Excellence) surgical recovery program, extending care beyond the hospital before and after surgery.

Frontline Healthcare Partners, a healthcare-focused private equity firm, acquired Integracare Inc., a private-pay home care company serving Ontario, Canada. Frontline took a controlling interest and will partner with Integracare President & CEO Lee Grunberg to support continued organic growth and acquisition-driven expansion.

PharmaCorp Rx Inc. completed the acquisition of a 100% interest in an arm’s-length pharmacy business located in Western Canada for $2.4 million, funded with cash on hand. The transaction marks PharmaCorp’s fourth completed pharmacy acquisition and was completed in conjunction with its strategic alliance with PharmaChoice Canada Inc.

Doximity, Inc. acquired Pathway Medical Inc., a Montreal-based startup focused on AI-driven, evidence-based clinical reference tools and medical datasets. The deal closed on July 29, 2025 for $26 million in cash plus up to $37 million in additional equity grants (up to $63 million total consideration).

WELL Health Technologies Corp. closed the acquisition of two outpatient clinics in British Columbia on July 1, 2025, adding a personalized health clinic in Vancouver and a primary care and specialty clinic in Burnaby. WELL expects the acquisitions to contribute more than $12 million in annual revenue and approximately $3 million in Adjusted EBITDA, further expanding its Canadian clinics network and longevity/preventative health offerings.

VitalHub Corp. has acquired Novari Health Inc., a Canada-based healthcare software provider focused on patient flow and referral management solutions. The transaction included $43.6 million of up-front consideration (cash and VitalHub shares) plus a potential $5.0 million all-cash earnout over two years, and is intended to strengthen VitalHub’s position in the Canadian referral management/patient flow market and support international expansion.

MDBriefCase (MDBC), a Think Research subsidiary, announced it has acquired Postcall.ca, a fast-growing newsletter for physicians. The deal adds Postcall’s weekly curated content on medicine, technology, investing, and healthcare policy to MDBC’s portfolio, supporting MDBC’s strategy to expand digital content for the medical learning community.

Fullscript announced an expanded investment from HGGC and Snapdragon Capital Partners to fund its next phase of growth. The new capital is supported by a continuation vehicle led by Leonard Green & Partners as the sole lead investor, providing liquidity options for existing investors while backing the company’s ongoing expansion.

Mable Health Inc. has acquired Winnipeg-based Anderson Orthopedics to expand its national orthotics, prosthetics, and mobility aids footprint in Canada and enter the Manitoba market. As part of the transaction, Anderson Orthopedics’ existing shareholders will roll over into equity of Mable Health and continue operating clinics in Winnipeg and Brandon, Manitoba.

Fengate Private Equity made a new platform investment in eMAX Health, partnering with the company to support growth and innovation in healthcare technology and tech-enabled pharmaceutical commercialization. eMAX’s existing management team, led by founder Julian Casciano, will continue to run the business and will remain significant investors alongside Fengate; transaction terms were not disclosed.

WELL Health Technologies Corp. completed seven acquisitions between December 2024 and January 2025 across its Canadian Clinics, WELLSTAR, and WELL USA/CRH business units, adding approximately $100 million in annualized revenue run-rate. The transactions included the acquisition of Jack Nathan Health, multiple primary care clinics in British Columbia and Ontario, Physicians For You (a Canadian physician recruitment firm), two WELLSTAR healthcare technology/EMR assets, and a 65% majority stake in Harmony Anesthesia Staffing in the United States.

Myant Corp. acquired mmHg Inc., a digital health company focused on remote blood pressure monitoring, cardiovascular risk reduction, and chronic disease management. The deal expands Myant’s geographic footprint and market reach into the United States and strengthens its AI-enabled, precision-medicine strategy for personalized remote cardiovascular care.

Trive Capital and 808 Capital Partners announced an investment in Crunch Canada Holdings Inc., the primary Crunch Fitness franchisee in Canada. Crunch Canada operates 19 corporate-owned gyms and supports 13 franchised clubs, and plans to use the partnership to expand club development, enhance capabilities, and pursue select acquisitions.

WELL Health Technologies Corp. completed the acquisition of Jack Nathan Medical Corp.'s Canadian clinical assets, including a network of owned and operated primary care clinics and a clinic-licensing business, and also obtained rights/framework to operate and expand clinics within Walmart Canada stores. The transaction brings a total clinic footprint reported as 13 owned clinics and 59 licensee clinics at close (72 total), with earlier reporting citing 16 owned and 62 licensee clinics, and WELL expects to drive synergies and reach adjusted EBITDA profitability in 2025.

Move Health Holdings Corp. acquired Fountain Wellness, a multidisciplinary healthcare clinic and medical spa in British Columbia’s Lower Mainland. The deal expands Move Health’s allied healthcare footprint and marks its entry into the medical spa and longevity services segment.

Integracare Inc., a private home healthcare provider in the Toronto area, expanded in Ontario by acquiring the Living Assistance Service franchise serving Burlington and Oakville. The acquired business provides personal care and in-home nursing services, and Integracare plans to enhance offerings in the region with expanded care management and additional in-home therapies.

Fullscript announced it has acquired Rupa Health, a lab ordering and results-management platform for healthcare practitioners. The combination will integrate Rupa Health’s lab and education offerings with Fullscript’s whole person care platform to scale a comprehensive clinical workflow; financial terms were not disclosed.

PharmaCorp Rx Inc. completed the acquisition of a 100% interest in a pharmacy business in Atlantic Canada, including the related land and buildings. The aggregate purchase price was $15,377,013, funded primarily with cash on hand and partially through the issuance of PharmaCorp common shares.

Better Choice Company Inc. signed a definitive agreement to acquire SRx Health Solutions Inc. in an all-stock transaction valued at approximately $125 million. SRx Health operates a national specialty pharmacy and healthcare services network across Canada, and the combined company expects to realize operational and growth synergies following an anticipated closing in the fourth quarter of 2024.

CPS Capital completed a go-private transaction to acquire all issued and outstanding common shares of CloudMD Software & Services Inc. via a court-approved plan of arrangement. CloudMD shareholders will receive C$0.04 per share in cash, and the company’s shares are expected to be delisted from the TSX Venture Exchange with an application to cease being a reporting issuer in Canada.

HEALWELL AI Inc. has acquired BioPharma Services Inc., a Toronto-based contract research organization (CRO) specializing in early-stage clinical and bioequivalence trials, from Think Research Corporation. The acquisition expands HEALWELL’s clinical research capabilities by combining BioPharma’s CRO operations with HEALWELL’s AI and data science platform and broader clinical network access in Canada.

Quest Diagnostics reached a definitive agreement and subsequently completed the acquisition of LifeLabs from OMERS for approximately CAN$1.35 billion (about US$985 million–$1.0 billion), including net debt. Quest acquired 100% of LifeLabs’ equity; LifeLabs will continue operating under its brand with the same management team and Toronto-area headquarters. The deal is expected to generate about CAN$970 million in annual revenues and to support expanded access to advanced diagnostics, improved patient service operations, and enhanced data security while keeping Canadian patient health data in Canada.

Numinus Wellness Inc. signed a letter of intent to acquire MedBright AI Investments Inc. via a statutory plan of arrangement. Under the proposed all-share transaction, Numinus will issue 1.86 Numinus shares for each MedBright AI share, resulting in MedBright AI shareholders owning approximately 39% of the pro forma company (undiluted). Numinus plans to rebrand as “Numinus Intelligence” upon closing and use MedBright’s AI capabilities to expand AI-enabled offerings for mental health clinics across the United States.

Mable Health Inc. announced the acquisition of Kingston-based V2 Innovations Ltd., expanding Mable Health's orthotics, prosthetics, and mobility aids operations into Ontario. As part of the transaction, V2 Innovations’ shareholders will become shareholders of Mable Health and V2 will continue operating from its two existing locations while integrating into Mable Health’s national platform strategy.

Radformation, Inc. acquired privately held Limbus AI, a provider of AI-driven automated contouring software for radiation therapy. The deal expands Radformation’s AI-based capabilities in radiation oncology treatment planning and aims to integrate both companies’ platforms to accelerate innovation and improve clinical workflow efficiency and patient outcomes.

Reverba, a patient engagement solutions provider to biopharmaceutical companies, acquired Six Degrees Worldwide Inc., a global medical communications firm. The deal, backed by Reverba’s growth capital partner 424 Capital, is intended to combine Six Degrees’ medical communications capabilities with Reverba’s patient engagement platforms to better translate complex scientific information for patients and healthcare stakeholders.

Charles River Laboratories’ AccelLAB business was acquired by key members of the AccelLAB management team in a management buyout. Following the transaction, AccelLAB will operate independently as a standalone preclinical contract research organization (CRO) focused on preclinical studies for the medical device market.

NeuPath Health Inc. announced the closing of its acquisition of the assets of SIBI Medical Inc., which operates as the London Spine Institute. The clinic adds back, neck, and spine specialists and expands NeuPath’s presence in London, Ontario, with operations continuing under the London Spine Institute name initially.

Integracare Inc., a private home healthcare provider in the Greater Toronto Area, has acquired Living Assistance Services. Living Assistance Services has provided personal support and home healthcare services in Toronto since 2000 and will be integrated into the Integracare Group of Companies.

Arch Amenities Group acquired Personal Best Health and Performance Inc. to expand its wellness, spa, and amenity management operations into Canada. Personal Best, headquartered in Palgrave, Ontario, provides corporate wellness consulting and management services for employee fitness and lifestyle programs.

Mable Health Inc. announced the acquisition of Whitby-based Design Prosthetics and Orthotics Inc. (DP&O) to strengthen its presence in Ontario. As part of the transaction, DP&O shareholders will roll equity into Mable Health and continue operating from their current location while providing prosthetic and orthotic services.

Sygnature Discovery, a UK-based integrated drug discovery contract research organisation (CRO), acquired Canada-based NuChem Sciences, one of North America's largest discovery CROs. The deal expands Sygnature’s North American footprint and combines UK and North American discovery capabilities to support drug discovery programs from target validation through candidate selection.

Sun Life Financial Inc. entered into an arrangement agreement to acquire all outstanding common shares of Dialogue Health Technologies Inc. for C$5.15 per share, valuing Dialogue at approximately C$365 million on a fully diluted basis. Dialogue will continue to operate as a standalone entity headquartered in Montréal, Québec, with certain members of executive management rolling equity and retaining a minority stake post-close.

The Riverside Company has invested in Montreal-based liV Inc., a provider of evidence-based medical education services and medical communications content for pharma medical affairs teams in Canada. The investment is an add-on to Riverside’s portfolio company, Clinical Education Alliance, LLC, expanding CEA’s medical communications capabilities and strengthening its presence in the Canadian market.

Krystal Growth Partners made an investment in Circle Wellness to fund the construction and launch of Circle Wellness’ flagship private self-guided thermal spa location. The new facility is planned for Granville Island in Vancouver, and will feature multiple bookable private “Circuit” wellness experiences.

GraceMed announced the acquisition of Canadian Dermatology Centre, a dermatology and plastic surgery clinic located in the Greater Toronto Area. The partnership supports GraceMed’s strategy to expand its North American footprint and broaden patient access to dermatology, plastic surgery, and medical aesthetics services.

Genesis Drug Discovery & Development (GD3), a member of Genesis Global Group, acquired JSS Medical Research to expand its clinical services portfolio. JSS Medical Research, headquartered in Montreal, adds pre- and post-approval clinical development capabilities and global clinical trial support services to GD3’s CRO platform.

Dynacare, a subsidiary of Labcorp, entered into an agreement to acquire Valley Medical Laboratories, effective May 1, 2023. The acquisition expands Dynacare’s presence in British Columbia and combines the two organizations’ patient service centre network and diagnostic testing offerings across Valley Medical’s 14 locations in the Okanagan Valley.

Canada Diagnostic Centres (CDC), backed by private equity firm Novacap, acquired Women's Ultrasound Clinic (WUC), a two-location women's ultrasound provider in Ottawa. The deal marks CDC’s entry into Ontario and expands its women’s imaging services footprint in Canada.

Canada Diagnostic Centres (CDC) announced the acquisitions of Guardian Radiology and The Ultrasound Centre (TUC) to expand its medical imaging footprint in Western Canada. The transactions strengthen CDC’s presence in Saskatchewan and reinforce its standing in Alberta and British Columbia. Novacap is cited as CDC’s partner supporting the company’s continued growth.

HID acquired GuardRFID, a provider of real-time location services (RTLS) and active RFID hardware and software solutions for healthcare facilities. The deal expands HID’s healthcare and IoT offering, adding GuardRFID’s solutions for infant security, staff duress, asset tracking, and patient wandering.

Medline Canada Corporation acquired Calgary-based Stat Healthcare Corporation, a provider of medical and laboratory supplies with expertise in clinic set-ups. Following the transaction, Stat Healthcare will operate as a division of Medline Canada, expanding Medline’s distribution footprint and ability to serve customers across Canada, particularly in Western Canada.

L Catterton announced that its portfolio company FYihealth Group completed a merger of its Medical Aesthetics division with Functionalab Group. The combined business will operate under the Functionalab Group name as a large aesthetic medicine clinic network in Canada. L Catterton and L'Oréal will be strategic partners and investors in the merged company.

ELNA Medical, a Montreal-based network of medical clinics, announced it has acquired m-Health Solutions, a provider of in-home cardiac diagnostics and real-time remote patient monitoring. The deal expands ELNA’s in-home patient monitoring capabilities through m-Health Solutions’ wearable ECG (Holter) technologies and cloud-based AI-enabled reporting services. National Bank Private Equity provided financial support to ELNA for the transaction.

The Best You (TBY), a group of medical aesthetic clinics in Ontario, completed the acquisition of Bay Street Salon and Spa, a family-owned salon and spa in Embrun, Ontario. The transaction expands TBY’s service offerings in the Greater Ottawa/Eastern Ontario region, with Bay Street adding salon, massage therapy, and laser aesthetics services and gaining access to additional medical-aesthetic services under TBY medical director Dr. Julie Lockman.

FGC Health announced it has finalized the acquisition of Lorimer Pharmacy and Health-Hub Medical Clinic. The deal marks FGC’s entry into the Manitoba physician and pharmacy market and expands its portfolio of pharmacies and medical clinics across Canada.

Ironbridge Equity Partners, together with management, completed the sale of Back in Motion Rehab Inc. to an entity controlled by Yorkville Asset Management Inc. Financial terms of the transaction were not disclosed.

headversity acquired the assets of Health Improvement Solutions (HIS), an evidence-based provider of health and wellness program planning, evaluation, and related services. The acquisition adds HIS’s health risk assessment methodology and behavior change support capabilities into headversity’s workforce mental health and resilience platform.

Innovaderm, a Montreal-based dermatology-focused contract research organization (CRO), acquired Excelsus Statistics to expand its biometrics capabilities. Excelsus Statistics provides biostatistics and SAS programming services, including expertise in adaptive trial design, and the combination will enable Excelsus’ clients to access Innovaderm’s broader full-service CRO offering including data management.

WELL Health Technologies Corp. entered into an asset purchase agreement to acquire the assets of INLIV Inc., an omni-channel primary care and preventative, corporate, and executive health provider in Calgary, Alberta. The transaction is expected to close in Q3 2022 and includes upfront consideration of approximately $1.61M plus a 120-day holdback of about $0.24M, payable in cash, shares, or a combination.

TELUS Corporation entered into a binding arrangement agreement to acquire all issued and outstanding common shares of LifeWorks Inc. in a cash-and-stock transaction. LifeWorks shareholders may elect cash, TELUS shares, or a combination (subject to proration), valuing the deal at approximately C$2.9 billion including net debt. The acquisition is intended to combine LifeWorks with TELUS Health to create a global, employer-focused digital-first healthcare and wellbeing platform.

The Kensington Private Equity Fund (Kensington) acquired Resolute Health Corporation Limited, a Canadian healthcare services provider focused on testing and treatment for obstructive sleep apnea. Resolute will partner with Kensington to expand its geographic reach and continue scaling its network of sleep therapy clinics across Canada.

Peloton Capital Management (PCM) announced an investment partnership with Victoria Park Medispa, a Canadian network of physician-led medical aesthetics clinics. The capital will support Victoria Park in expanding its national footprint and continuing organic growth; financial terms were not disclosed.

Harris, a vertical market software provider, acquired Sedona Learning Solutions, which provides custom eLearning and education consulting to hospitals across the United States and Canada. Following the transaction, Sedona will become a division of iatricSystems, a Harris Healthcare company focused on healthcare technology, EHR optimization, interoperability, privacy, and analytics.

Integracare Inc., a private home healthcare provider in Toronto and Mississauga, acquired Guardian Home Care. Guardian provides senior home care services in Toronto and surrounding areas, including personal care and in-home nursing such as overnight care, expanding Integracare’s capabilities in dementia care and personal support at home and in care facilities.

Premier Health of America Inc. entered into a share purchase agreement to acquire 100% of Umana Holdings Inc. and its wholly owned subsidiary, Canadian Health Care Agency (CHCA), via its newly formed subsidiary 13822214 Canada. The cash consideration is up to C$14.5 million (cash at closing plus potential deferred payments tied to performance), and CHCA will become a wholly owned subsidiary of Premier Health following the transaction and reorganization. CHCA provides specialized nursing services, including staffing for remote and semi-remote Indigenous communities in Canada, and is based in Cambridge, Ontario.

Probo Medical, a global provider of medical imaging equipment, parts, repair and service, completed its acquisition of Canute Medical. Canute Medical provides installation, de-installation, removals, and remarketing services for pre-owned imaging equipment including MRI, CT, X-Ray and Gamma Cameras, and is headquartered in Oakville, Ontario. Financial terms were not disclosed; Probo Medical is backed by Avista Capital Partners.

Mednow Inc., a Canadian on-demand virtual pharmacy and healthcare technology company, completed its previously announced acquisition of all issued and outstanding voting shares of Mednow Pharmacy Inc. ("Mednow East"). The consideration included approximately C$65,578 in cash and the conversion of about C$1,374,422 owed by Mednow East to Mednow into a non-interest bearing on-demand convertible promissory note. Mednow East’s results will be consolidated into Mednow and the existing pharmacy agreement between the parties will be terminated.

CareRx Corporation entered into a definitive asset purchase agreement to acquire Hogan Pharmacy Partners Ltd., a long-term care pharmacy serving residents in long-term care and retirement homes in Ontario. The transaction consideration includes $2.2 million in CareRx common shares and a $2.2 million vendor take-back note, and includes the acquisition of Hogan’s Canadian patent application related to its technology-enabled “Hogan Model.” Closing is expected to occur in May 2022.

Loblaw Companies Limited, through its wholly owned subsidiary Shoppers Drug Mart, agreed to acquire Lifemark Health Group from Audax Private Equity for aggregate cash consideration of $845 million. Lifemark is a leading Canadian provider of outpatient physiotherapy and rehabilitation services with more than 300 clinics nationwide. The transaction is subject to regulatory approvals and is expected to close in the second quarter of 2022.

Neighbourly Pharmacy Inc. entered into a definitive agreement to acquire all shares of the entity that owns and operates Rubicon Pharmacies, a 100-location network of community pharmacies in Western Canada, for $435 million in cash (subject to customary adjustments and ROFR-related exclusions). The deal is expected to close in Q2 2022 and will be financed through a combination of equity (including a public subscription receipt offering and a concurrent investment by Persistence Capital Partners) and credit facilities/cash on hand.

Mednow Inc. completed the acquisitions of all issued and outstanding shares of London Pharmacare Inc. and Liver Care Canada Inc. The amended deal terms for London Pharmacare include C$1.0 million paid at closing plus two deferred cash payments of C$367,500 on the first and second anniversaries of closing. Mednow expects to integrate both businesses with its technology and specialty pharmacy operations to expand specialty pharmacy and clinical services focused on liver disease.

Venn Growth Partners and BDC Capital acquired Monarch House Ltd., carving it out from CBI Health and establishing Monarch House as an independently operated, Canadian-owned private business. Monarch House will continue operating its network of interdisciplinary behavioural health centres focused on children and youth with autism spectrum disorder, with the existing management team remaining in place. Financial terms were not disclosed.

Alira Health, a global healthcare consulting and technology firm, acquired Self Care Catalysts, Inc., a digital health company headquartered in Toronto, Canada. The deal expands Alira Health’s patient-centric digital health portfolio, adding Self Care Catalysts’ Health Storylines platform supporting decentralized clinical trials (DCT) and real-world evidence (RWE).

Ampersand Capital Partners announced the sale of its portfolio company Nexelis to Q2 Solutions, a global clinical trial laboratory services organization and wholly owned subsidiary of IQVIA, Inc. Nexelis, formed in 2015 as a spin-out from GSK's Vaccine Clinical Laboratory Services unit in Laval, Quebec, provides assay development and advanced laboratory testing services supporting drug development.

Mednow Inc., a Canadian on-demand virtual pharmacy, closed its acquisition of Infusicare Canada Inc. for a cash payment of C$1.85 million. Infusicare is a specialty pharmacy focused on biologic drugs and related patient support services, and generated C$9.3 million in revenue in its latest fiscal year. The transaction was structured as a share purchase and was disclosed as a related-party transaction due to overlapping directors/shareholders.

Fengate Private Equity, a division of Fengate Asset Management, completed a strategic minority equity investment in Grace Clinics Corp. (GraceMed) on behalf of the LiUNA Pension Fund of Central and Eastern Canada. GraceMed’s management team and existing shareholders will retain a significant equity interest. The investment is intended to provide additional growth capital and strategic support to expand GraceMed’s physician-led aesthetic medicine and clinic network across Canada.

Beatrice Society, a Toronto-based psychedelics and mushroom company focused on psychotherapy-driven outcomes, acquired psychedelic enhanced psychotherapy company MindSetting. The deal is intended to accelerate adoption of MindSetting’s TRIP Protocol for ketamine-assisted therapy and expand clinician training and education programs across Canada. Beatrice also plans to explore broader clinical use of psychedelics such as MDMA and psilocybin.

HGGC and Snapdragon Capital Partners signed a definitive agreement to make a $240 million strategic growth investment in Fullscript. The investment is intended to expand Fullscript’s platform across the patient treatment lifecycle and support continued investments in technology, partnerships, and acquisitions.

Integracare Inc., a private home healthcare provider in Toronto and Mississauga, has acquired Eldercare Home Health Inc. Eldercare has provided RN-supervised, case-managed home healthcare and personal support services for seniors in Toronto and the Greater Toronto Area since 1995.

Finvasia announced its acquisition/investment in Gini Health, a Canada-based healthcare technology company focused on DNA- and lifestyle-data-driven personalized preventive care. The deal results in the exit of prior investors, with Finvasia and Gini Health founder/CEO Gurjot Narwal becoming key stakeholders while Narwal continues to lead the business.

Mednow Inc. completed its previously announced acquisition of all issued and outstanding shares of Mednow Pharmacy Inc. ("Mednow West"). The deal consideration included approximately $74,000 in cash and Mednow’s agreement to convert about $908,000 owed under an existing pharmacy agreement into a non-interest bearing on-demand convertible promissory note. Mednow West, an online pharmacy headquartered in Vancouver, will be consolidated into Mednow and the pharmacy agreement between the parties will be terminated.

LifeSpeak Inc. has completed the acquisition of ALAViDA Health Ltd., a virtual SaaS-based provider of cognitive-behavioral therapy solutions for substance use disorders. The deal is intended to deepen LifeSpeak’s behavioral health capabilities and create cross-sell opportunities across both companies’ enterprise customer bases. Total consideration is $12 million, consisting of $7 million in cash plus up to $5 million in earnout tied to 2022 performance milestones.

ELNA Médical, a Montreal-based network of primary and specialized care clinics in Canada, announced the acquisition of GMF Roger Laberge (formerly Clinique médicale Châteauguay). The clinic, a major medical clinic in Montérégie-Ouest, provides family and preventive medicine services and walk-in consultations. The seller/owner Gilles Fleury stated the clinic will now become part of ELNA Médical’s broader network and services.

ELNA Médical (ELNA) announced the acquisition of Métro Médic Centre-Ville, a “super-clinic” providing primary and specialized medical services in downtown Montréal. With this deal, Métro Médic becomes ELNA’s 60th clinic, strengthening ELNA’s presence in strategic urban locations and supporting its growth plan as Canada’s largest clinic network.

Green Shield Canada (GSC), through Green Shield Holdings Inc., announced the acquisition of Tranquility Online, a Halifax-based digital mental health platform offering internet-based cognitive behavioural therapy (iCBT) and coaching. The deal expands GSC’s digital mental health ecosystem and is intended to support integrated offerings alongside GSC’s existing digital mental health assets such as Inkblot Therapy.

Mednow Inc. acquired 2716725 Ontario Inc. dba Medvisit, Canada’s largest and longest-standing doctor home-visit (house call) provider. The deal includes $1,320,000 in cash at closing plus a conditional earn-out of up to $680,000 tied to profitability milestones. Mednow plans to integrate Medvisit’s physician home-visit network and patient base to expand its holistic healthcare offering alongside its virtual pharmacy and telehealth services in Ontario.

Levitee Labs Inc. completed the acquisition of the majority of the operating assets of ACT Medical Centres Inc., including five addiction treatment clinics across Alberta. The clinics, located in Calgary, Medicine Hat, Red Deer, Grande Prairie, and Lethbridge, recorded over 35,000 patient visits in the prior 12 months and will be integrated into Levitee’s mental health and addiction services portfolio. Levitee paid $350,000 in cash at closing.

EVERSANA acquired Toronto-based Accelera Canada along with its partner companies Patient Access Solutions, Podium Strategic Partners, Inc., and Advocacy Solutions. The deal expands EVERSANA’s global life-sciences commercialization capabilities, adding strength in consulting, market access, patient advocacy, and patient support services across Canada. Financial terms were not disclosed, and Accelera Canada’s founding partners and team will join EVERSANA with legacy brands to be integrated over the coming months.

Mednow Inc. invested $500,000 for an initial 9% equity interest in Life Support Mental Health Inc. (LSMH), with an option to invest an additional $1,000,000 in tranches to increase its stake to approximately 18% upon milestone achievement. Mednow also signed a non-binding letter of intent to acquire an unnamed Ontario-based medical business through a purchase of all outstanding shares, with cash consideration expected to include an earn-out.

The Fertility Partners (TFP) announced the acquisition of Conceptia Fertility, a full-service fertility clinic based in Moncton, New Brunswick. TFP plans to invest in additional human resources and facility upgrades to expand access to fertility care across Atlantic Canada.

WELL Health Technologies Corp. entered into a definitive share purchase agreement to acquire all issued and outstanding shares of MyHealth Partners Inc. for C$206M plus a conditional earn-out of up to C$60M. MyHealth operates 48 primary, specialty, telehealth, and diagnostic care locations across Ontario, and the acquisition is expected to make WELL the largest owner-operator of outpatient medical clinics in Canada and a leading multi-disciplinary telehealth provider.

FFL Partners, Caisse de dépôt et placement du Québec (CDPQ), and the Dr. H. Doug Barnes Family completed the acquisition of New Look Vision Group Inc., purchasing all outstanding Class A common shares for $50.00 per share in cash (with certain shareholders receiving purchaser common shares). Following the transaction, New Look Vision is expected to be delisted from the Toronto Stock Exchange and seek to cease being a reporting issuer in Canada.

Myconic Capital Corp. (formerly Auralite Investments Inc.) signed a letter of intent to acquire 100% of Integrated Rehab and Performance Ltd. (IRP), a multidisciplinary physical therapy clinic focused on Canadian Armed Forces, RCMP, and first responder patients. The transaction consideration is $1,000,000 paid in Myconic common shares, with additional milestone-based share bonuses tied to clinic expansion, revenue targets, and studies, and is subject to definitive documentation, due diligence, and board approvals.

Peloton Capital Management (PCM) announced an investment in Edgewood Health Network (EHN) Canada, a national provider of inpatient and outpatient mental health and addiction services. The capital will support EHN Canada’s expansion across Canada, including acquiring and developing additional private mental health facilities and growing its online outpatient clinic, EHN Online. Financial terms were not disclosed.

WELL Health Technologies Corp. entered into a definitive agreement to acquire all issued and outstanding shares of ExecHealth Inc., an omni-channel provider of primary care and executive health services in Ottawa, Ontario. The transaction, expected to close in early May 2021, includes cash, WELL common shares, and a performance-based earn-out, and represents WELL’s first acquisition of clinical assets in Ontario.

Alimentiv Health Trust (parent of Alimentiv, Inc.) announced it has acquired McDougall Scientific Ltd., a niche contract research organization focused on biostatistics, data management, reporting, and clinical trial design. The deal expands Alimentiv’s capabilities in statistical analysis and data services for clinical trials, while McDougall’s founder Janet McDougall will retire and remain as a consultant during the transition.

Novo Holdings A/S agreed to acquire Altasciences, a fully integrated early drug development services platform, from Audax Private Equity. Altasciences, headquartered in Laval, Quebec, provides preclinical safety testing through clinical proof-of-concept services for pharma and biotech customers and operates six facilities across the United States and Canada. The deal (announced Feb. 22, 2021) was completed in March 2021, and Altasciences’ management team led by CEO Chris Perkin will continue to run the business.

WELL Health Technologies Corp. entered into an arrangement agreement to acquire all outstanding shares of CRH Medical Corporation for US$4.00 per share in cash, valuing the equity at approximately US$292.7M (about US$369.2M including CRH debt facilities). The transaction is intended to expand WELL’s presence in the United States and will be funded through a concurrent C$295.5M private placement led by Mr. Li Ka-shing, alongside committed credit facilities and cash on hand.

X-Chem, Inc., a provider of DNA-encoded library (DEL)-based drug discovery services, acquired Montreal-based drug discovery services company IntelliSyn and its US-based sister company, AviSyn. The deal expands X-Chem’s capabilities into downstream medicinal chemistry, custom synthesis and process chemistry to provide a more integrated screen-to-lead offering for pharma and biotech clients. Financial terms were not disclosed, and IntelliSyn founder/CEO Jeffrey Albert will join X-Chem’s management team.

The Fertility Partners (TFP) announced the acquisition of The Toronto Institute for Reproductive Medicine (TTIRM) and ReproMed, expanding its fertility clinic network in Ontario. The deal increases TFP’s Greater Toronto Area footprint to five locations and adds Canadian donor sperm services through ReproMed.

Caprion-HistoGeneX, a contract research laboratory services provider backed by Arsenal Capital Partners, acquired Clinical Logistics Inc. (CLI), a virtual central specimen management CRO based in Halifax, Canada. The deal expands Caprion-HistoGeneX’s specimen logistics and management capabilities to better support global clinical trial needs for pharma and biotech customers.

Arlington Capital Partners made a majority investment in Everest Clinical Research Corporation in partnership with Everest’s founding shareholders and senior management. Everest will continue to be led by its existing management team and will use the investment to support further growth and expanded clinical research service capabilities.

ACTO, an omnichannel education and engagement SaaS platform for life sciences, acquired CoHealth, a mobile application for delivering trusted health resources to patients and caregivers. The acquisition adds direct-to-patient education capabilities and a new division to ACTO’s platform, marking ACTO’s second strategic acquisition after raising $11.5 million earlier in 2020.

ClinicalMind, LLC (CM) acquired IC Axon, a provider of science-driven clinical and sales training solutions for pharmaceutical and life science companies. The deal expands ClinicalMind’s healthcare communications offering by adding IC Axon’s digital learning strategies and training capabilities for pharma and biotech clients.

MDBriefcase Group Inc. (MDBriefcase) announced the acquisition of OncologyEducation, an online platform providing evidence-based oncology education content authored by an international faculty. The deal expands MDBriefcase’s oncology-focused continuing medical education offerings and extends its reach to healthcare professionals globally.

CAI Capital Partners closed an investment in RebalanceMD Canada Ltd., a Victoria, British Columbia-based operator of musculoskeletal care medical clinics offering orthopedic surgical procedures and non-surgical services. The investment will fund RebalanceMD’s growth through opening new clinics initially in British Columbia and Alberta, with longer-term expansion across Canada.

Peloton Capital Management (PCM) made a significant investment in The Fertility Partners (TFP), described as Canada’s largest network of fertility clinics. The investment will support the launch and expansion of TFP through partnerships with leading fertility clinics across British Columbia, Manitoba, Ontario, and Quebec, as well as building back-office, marketing, and operational capabilities. Financial terms were not disclosed.

Sotera Health announced that its Sterigenics business has acquired Canadian-based Iotron Industries. The deal expands Sterigenics’ electron beam (EBeam) sterilization footprint in North America and adds expertise and proprietary accelerator technology used for medical device sterilization and other industrial applications.

National Seating & Mobility (NSM) announced the acquisition of PG Surg Med, a regional mobility provider with multiple locations across British Columbia, Canada. The deal makes NSM the largest provider of mobility solutions in British Columbia and marks NSM’s first entry into the province’s Northern Region.